Presentation TCT 2012 TCT-22. Combination of High Wall Shear Stress, Plaque Burden, and Plaque Phenotype has Incremental Value for Prediction of Increased Plaque Vulnerability in Patients with... Presenter: Michel Corban October 23, 2012
Presentation TCT 2012 TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable... Presenter: Michael Haude October 23, 2012
Presentation TCT 2012 Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis? Presenter: Bernard De Bruyne October 23, 2012
Presentation TCT 2012 Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For Presenter: Horst Sievert October 23, 2012
Presentation TCT 2012 TCT-7. Plaque Excision as a Treatment Option for Critical Limb Ischemia: 1-Year Results of the DEFINITIVE LE Study Presenter: James McKinsey October 23, 2012
Presentation TCT 2012 TCT-4. Impact of Catheter Fragmentation Followed by Local Intrapulmonary Thrombolysis in Acute High Risk Pulmonary Embolism as Primary Therapy: Acute and Long Term Outcomes Presenter: Bishav Garg October 23, 2012
Presentation TCT 2012 TCT-371. First Clinical Evaluation of a Novel Percutaneous Right Ventricular Assist Device: The Impella RP Presenter: Anson Cheung October 23, 2012
Presentation TCT 2012 TCT-71. Intravascular Ultrasound-guided Systematic Two-stent Techniques for Coronary Bifurcation Lesions Reduced Late Stent Thrombosis and ST-elevation Myocardial Infarction Presenter: Shao Liang Chen October 23, 2012
Presentation TCT 2012 Vulnerable Plaque Is a Systemic Inflammatory and Vascular Disease Presenter: Valentin Fuster October 23, 2012